Apotex Inc. v. Eli Lilly Canada Inc., (2011) 426 N.R. 173 (FCA)
Linked as:
Extract
Apotex Inc. v. Eli Lilly Canada Inc., (2011) 426 N.R. 173 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Apotex Inc. v. Abbott Laboratories Ltd. et al., [2010] O.T.C. Uned. 6909 (SC)
- Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
- Zaidan Group Ltd. v. London (City), (1990) 36 O.A.C. 384 (CA)
- Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (1996) 113 F.T.R. 241 (TD)
- AstraZeneca Canada Inc. v. Canada (Minister of Health) et al., (2006) 354 N.R. 88 (SCC)
